High-dose chemotherapy followed by autologous stem cell transplantation for …Nature.comAlthough patients with relapsed or refractory PMBL are often treated with high-dose therapy followed by autologous stem cell transplantation (HDT/ASCT) after salva… Continue reading
High-dose chemotherapy followed by autologous stem cell transplantation for …Nature.comAlthough patients with relapsed or refractory PMBL are often treated with high-dose therapy followed by autologous stem cell transplantation (HDT/ASCT) after salva… Continue reading
|
Patent Issued for Methods of Producing Stem Cell Conditioned Media to Treat …
Equities.com “However, embryonic stem cells have limitations in their ability to be used clinically, as they must be derived from another individual–an embryo. This not only raises a potential that the patient will reject the cells, but it also severely limits the … |
|
Patent Issued for Methods of Producing Stem Cell Conditioned Media to Treat …
Equities.com “However, embryonic stem cells have limitations in their ability to be used clinically, as they must be derived from another individual–an embryo. This not only raises a potential that the patient will reject the cells, but it also severely limits the … |
Xconomy |
NY Stem Cell Foundation Grows, Eyes Forming Big Apple Bio Incubator
Xconomy According to Susan Solomon, the CEO and co-founder of the NYSCF—a roughly 10-year-old entity that is one of the world leaders in stem cell research—the nonprofit plans to start spinning out its work into companies, and wants to create an in-house … |
The Australian |
Cytomatrix to create $100m US-based stem cell operation
The Australian An Australian stem cell company has pulled off one of the country’s biggest research licensing deals, turning a $21 million local operation into a newly created US-based $100m outfit to progress “game-changing” treatment for cancer patients using … |